Back to Blog

Cryonics on the move: expanding our standby capabilities across Europe

Tomorrow.bio has deployed new ambulances, significantly expanding our standby capacity for human cryopreservation. These vehicles enhance our ability to respond quickly, stabilize patients on-site, and improve preservation quality for terminal cases.
4 MINUTES
|
June 17, 2025
|
Announcement
Joana Vargas

Cryonics on the move: expanding our standby capabilities across Europe

At Tomorrow.bio, we know that timing is everything when it comes to cryopreservation. The moments immediately following legal death are critical. What happens during that short window can significantly impact the quality of preservation.

Newly acquired ambulaces forTomorrow.bio fleet

Why rapid response matters in cryonics

When a person facing a terminal illness chooses cryopreservation, it’s often because they believe in the possibility of a future their current care can’t provide. But even with the best planning, delays after legal death can limit that possibility.

Cryopreservation depends on minimizing biological change as quickly as possible. That means starting stabilization within minutes, not hours. These new ambulances make that more achievable, even across borders.

What makes these ambulances different

These are not ordinary emergency vehicles. Each unit has been custom-built to carry out cryopreservation protocols in the field. Features include:

Equipment for rapid field stabilization, including cooling systems and perfusion prep

Controlled temperature transport, maintaining low temperatures en route

Seamless integration with our long-term storage facilities, ensuring no time is lost during transfer

With this setup, our ambulances function as mobile extensions of our cryonics lab, allowing our standby teams to respond efficiently and perform critical tasks before a patient even arrives at the facility.

Strategic placement, stronger coverage

Each ambulance has been strategically deployed to reduce response times and broaden our reach across Europe. This means we can:

- Respond faster to emergency cases in more regions

- Improve coordination with local healthcare institutions and families

- Increase reliability and consistency in delivering on-site care

- Expand our ability to serve members who may not live near major cities

The goal is clear: to ensure that no matter where someone is located, they can rely on Tomorrow.bio to act quickly and professionally when the time comes.

Building an infrastructure for the future

This deployment is about more than geography, it's about commitment. With every new ambulance, we move closer to creating a continent-spanning infrastructure that supports high-quality cryopreservation at scale.

We believe cryopreservation should not be limited by distance or logistical constraints. By improving our ability to respond, wherever and whenever we’re needed, we’re laying the foundation for a future where this technology is truly accessible.

If you or someone you love is facing a terminal illness

We know how difficult these conversations can be. A diagnosis can bring fear, grief, uncertainty, and sometimes, a quiet hope for something more.

Cryopreservation is not a cure. But it is an opportunity: a way to preserve someone at the edge of what today can offer, with the hope that tomorrow may bring more.

Our expanded ambulance network reflects this commitment. If you want to know how the process works, what it involves, or whether it’s the right step for you or your family, we’re here. No pressure. Just honest answers, grounded in care and transparency.

What this means for the cryonics community

These new ambulances are more than equipment. They represent a vision, of a future where life doesn’t have to end simply because current science can’t yet do more.

Every kilometer gained, every minute saved, brings us closer to making that future a reality.